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Pathophysiology of ARDS 
Significance of 
Pathophysiology 
It 	is 	important 	to 	understand 	the 
pathophysiology of ARDS due to the
high	 mortality rate and the risk of
permanent damage to the body.
Understanding the pathophysiology
and signs and symptoms can help
diagnosis	 ARDS early before there is	
significant damage to the lungs. 
Treatment Strategies 
• Early detection 
• Management of contributing
etiologies 
• Support therapy to stop
progression of lung injury 
• Prevent complications such as
pneumonia and peptic ulcers 
(McCance & Huether,	 2014) 
Therapies 
• Mechanical ventilation with 
PEEP	 and high oxygen
concentrations 
• Prone positioning 
• Deep sedation	 and paralytics 
• Low-volume ventilation 
(Xie et al., 2020) 
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Risk Factors Signs and Symptoms 
• Acute onset of bilateral infiltrates • Genetic factors 
on x-ray • Sepsis 
• Low ratio of partial pressure of • Multiple trauma 
arterial oxygen to the fraction of • Aspiration 
inhaled oxygen • Pneumonia 
• Fine inspiratory crackles • Burns 
(McCance & Huether, 2014) • Cardiopulmonary bypass surgery 
• Shortness of breath • Radiation therapy 
• Refractory hypoxia • Overdose 
• Tachypnea • Smoking 
• Tachycardia • Pancreatitis 
• Fatigue • Disseminated intravascular 
• Fever coagulation (DIC) 

















Prone positioning can be used as a therapy for the management of ARDS. Patient 
positioning can play a large role in improving lung oxygenation. Prone positioning 
can help by: 
• Improving 	ventilation 	and 	perfusion 
• Move fluid in the lungs to improve ventilation 
• Improve 	atelectasis 
(NIH, 2019)
Prone positioning can either be achieved manually with three or more nurses and a
respiratory therapist, watching the airway, or by an automatic prone positioning
device such as	 the Rotaprone bed. When placing a patient in the prone position it is
important to apply foam pressure injury prevention stickers in high pressure areas




Nurses play a large role in early detection of ARDS and can have an impact in the
management of the disease. Some implementations that nurses can apply are: 
• Assessing for signs of sepsis 
• Fever 
• Tachycardia 




(McCance & Huether,	 2014) 
• Maintain the airway 
• Frequent change in	 patient positioning 
• Weaning protocol 
• Pulmonary toileting 
• Monitor frequent arterial blood gases 
(NIH, 2019) 
• Prevent complications 
• Pressure injury prevention 
• Patient oral hygiene 
• Nurse hand hygiene 
• Adequate patient nutrition 
• SCD device to prevent deep vein thrombosis 
(NIH, 2019) 
• Administer ordered medications 
• Steroids to help with inflammation 
• Antibiotics 
• Fluids or vasopressors 
(NIH, 2019) 
Conclusion 
ARDS is a serious life-threatening condition that is crucial for health care 
professionals to understand. By understanding the pathophysiology of ARDS and 
knowing the signs and symptoms can aid in early detection and prevention of severe 
lung injury. It is imperative for the bedside nurse to detect early signs of ARDS due to 
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Introduction 
Acute respiratory distress syndrome
(ARDS)	 is a lung condition characterized
by acute hypoxemia and bilateral
infiltrates after a triggered injury
(Senapathi et al., 2020). ARDS causes 
damage to pulmonary capillaries	 leading
to fluid accumulating in the alveoli. The 
accumulation of fluid in the	 alveoli 
causes an increase in work	 of breathing
and systemic hypoxemia	 ultimately
leading to mechanical	 ventilation. ARDS
has a high	 mortality rate of 35-46%
(Weiss et al., 2021). Those who do
survive ARDS can have permanent lung
damage and	 continued	 health problems	
(McCance & Huether,	 2014). 
ARDS has become more prevalent with 
the 2020 Covid-19 pandemic. “COVID-19 
causes acute respiratory distress syndrome 
(ARDS) in approximately 20% of 
hospitalised subjects with Covid-19” 
(Weiss et al., 2021, p. 49). Covid-19 is a 
global pandemic that has affected more 
than 200 countries, resulting in 1.1 million 
deaths so far (Weiss et al., 2021). 
Underlying 
Pathophysiology 
Lung injury due to ARDS causes release
of inflammatory mediators including
platelet-activating factors, complement
cytokines, arachidonic	 acid metabolites,
and reactive	 oxygen species	 (McCance &
Huether,	 2014). These inflammatory
mediators cause damage to the lung
epithelium causing damage	 to lung
capillaries. Neutrophils play a large role
in the progression of ARDS by releasing
more inflammatory mediators that cause
more damage to lung capillaries
increasing capillary permeability. This 
increase in pulmonary capillary
permeability causes proteins, fluids, and
blood cells to leak into the pulmonary
interstitium resulting in pulmonary
edema. The	 increased pulmonary edema	
causes decreased lung compliance and
impairs alveoli	 ventilation. Once the 
alveoli are	 damaged, they can no longer
produce surfactant leading to atelectasis
(McCance & Huether,	 2014).	
After about 2 to 3 weeks of injury
remodeling and fibrosis begins to occur	
further 	damaging 	the 	alveoli. 	Persistent 
hypoxemia and hypercapnia lead to	
respiratory failure, metabolic acidosis,
multiple organ failure and eventual
death (McCance & Huether,	 2014).	 
https://www.frontiersin.org/articles/10.3389/fphar.2020.572009/full 
Targeting neutrophils for COVID-19 associated ARDS 
ARDS 
·Criticalnon-cardiogeniclungedema 
· Caused by alveolar infection or 
inflammation 
·Lethal complication related 
toCOVID-19 
ANTI-VIRAL THERAPIES 
Targeting SARS-CoV-2 life cycle: 
•ACE•2receptOr 
- Spike protein RBD 
·Macrodomaln(Macl) 
• Main protease (Mpro, 3Clpro) 
• NetJtrophil infiltration, derived ox.idants, 
proteases, and NETs contribute to ARDS 
severity 
, STRATEGY: Target excessive neutrophil 
activationwhilepreservingneutrophil 
defensive mechanisms 
1. SARS-CoV-2 infection: 
real-time RT-PCR for nucleic acid (+) 
2. ARDS (Berlin criteria) ; 
·Acuteonset:<1week 









· Tidal volume: 6 ml/kg predicted BW 
· Plateau airway pressure:< 30 cm H,O 
3. Proneposition 
4. ECMO: severe cases based on EOLIA trial 
5. Antibiotics: secondary infection 
CMayo FoundaUon for Medical Educauon end R1111111rch A.II n,&hll reserved OTTERBEIN 
UNIVERSITY 
